[#item_full_content] Duane Boise, CEO, MMJ International Holdings stated, “Positioned with Active INDs, Orphan Drug Designations, and Standardized Soft-Gel Formulations, MMJ aligns with the FDA’s Botanical Drug Pathway as Federal Oversight Expands. As Schedule III Normalization … Read More

